세계의 액체생검 시장 예측(-2027년) : COVID-19의 영향과 제품 및 서비스별, 샘플별, 순환 바이오마커별, 용도별, 최종사용자별, 지역별 분석
Liquid Biopsy Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product and Services; Sample; Circulating Biomarker; Application; End User, and Geography
상품코드 : 935344
리서치사 : The Insight Partners
발행일 : 2020년 04월
페이지 정보 : 영문 195 Pages
US $ 4,550 ₩ 5,374,000
PDF by E-mail (Single User License)
US $ 6,550 ₩ 7,737,000
PDF by E-mail (Site License)
US $ 8,550 ₩ 10,100,000
PDF by E-mail (Enterprise License)


한글목차

세계의 액체생검 시장은 2019년에 38억 6,149만 달러에 달하고, 2020-2027년간 9.9%의 CAGR로 성장하여 2027년에는 81억 2,385만 달러에 달할 것으로 예측됩니다.

세계의 액체생검(Liquid Biopsy) 시장에 대해 조사 분석했으며, 시장 개요, 시장 규모와 예측, 부문별 시장 분석, 지역별 시장 분석, 경쟁 상황 등에 대한 체계적인 정보를 제공합니다.

목차

제1장 서론

제2장 액체생검 시장 - 중요한 포인트

제3장 조사 방법

제4장 액체생검 - 시장 상황

제5장 액체생검 - 주요 시장 역학

제6장 액체생검 시장 - 세계 시장 분석

제7장 액체생검 시장 분석 - 제품·서비스별

제8장 액체생검 시장 분석 - 샘플별

제9장 액체생검 시장 분석 - 순환 바이오마커별

제10장 액체생검 시장 분석 - 용도별

제11장 액체생검 시장 분석 - 최종사용자별

제12장 액체생검 시장 분석 - 지역별

제13장 COVID-19의 영향

제14장 업계 상황

제15장 주요 기업 개요

제16장 부록

KSM 20.06.08
영문 목차

영문목차

The liquid biopsy was valued at US$ 3,861.49million in 2019 and is projected to reach US$ 8,123.85 million by 2027; it is expected to grow at a CAGR of 9.9% from 2020 to 2027.

The growing prevalence of cancer is a driving factor for the growth of global liquid biopsy market. However, low sensitivity of liquid biopsy is likely to restrain the growth of the market during the forecast period.

Liquid biopsy is a noninvasive diagnostic test that identifies various types of cancer. The increasing prevalence of cancer among population is leading to the growth of liquid biopsy market across the world. For instance, in Canada, cancer is the leading cause of death among population and it is witnessed to be a second-leading cause after heart diseases in the US. As per the American Cancer Society, Inc, approximately, 1.9 million new cancer cases and 693,000 cancer deaths were recorded in 2018, in Northern America. Prostate cancers are the most commonly diagnosed cancers among males in North America; however, breast cancers remains leading in females. Additionally, lung cancer remains the most common cause of death in both sexes. It is estimated that the number of new cancer cases is accounted for 439.2 per 100,000 men and women every year.

According to the National Health Profile, the cases of common cancers, including cervical, oral, and breast cancers have increased by 324%in India between 2017 and 2018. Additionally, the total number of patients visiting Non Communicable Diseases (NCD) clinics have doubled from 2017 to 2018, which is recorded as 3.5 crore to 6.6 crore respectively. Rapid change in lifestyle and increasing consumption of alcohol and tobacco products are the factors increasing the incidences of cancer among the population.

The global liquid biopsy market is segmented into product & services, sample, circulating biomarker, application, and end user. The circulating biomarker is further segmented into circulating tumor cells (CTC), exosomes, and free nucleic acid. The circulating tumor cells (CTC) segment held the largest share of the market in 2019 and is anticipated to register the highest CAGR in the market during the forecast period. Based on application, the liquid biopsy market is segmented into oncology, noninvasive prenatal testing (NIPT), transplant diagnostics, and other applications. The oncology segment held the largest share in 2019 of the market; moreover, noninvasive prenatal testing (NIPT) is expected to register fastest growth. Furthermore, based on end user, the liquid biopsy market is segmented into hospitals, reference laboratories, academic & research institutes, and other end users. Hospitals segment is expected to remain dominant during the forecast period.

Cancer Center Amsterdam, Food and Drug Administration, World Health Organization (WHO),Kidney Disease Improving Global Outcomes, and International Diabetes Federation are some of the essential primary and secondary sources included in the report.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the liquid biopsy market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global breast cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction

2. Liquid Biopsy Market - Key Takeaways

3. Research Methodology

4. Liquid Biopsy - Market Landscape

5. Liquid biopsy- Key Market Dynamics

6. Liquid Biopsy Market - Global Analysis

7. Liquid Biopsy Market Analysis - By Product & Services

8. Liquid Biopsy Market Analysis - By Sample

9. Liquid Biopsy Market Analysis - By Circulating Biomarker

10. Liquid Biopsy Market Analysis - By Application

11. Liquid Biopsy Market Analysis - By End User

12. Liquid Biopsy Market - Geographic Analysis

13. Impact Of COVID-19 Pandemic On Global Liquid Biopsy Market

14. Liquid Biopsy Market -Industry Landscape

15. Liquid Biopsy Market, Key Company Profiles

16. Appendix

(주)글로벌인포메이션 02-2025-2992 koreainfo@gii.co.jp
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기